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Abstract   
Thioacetamide (TAA) administration is widely used for induction of liver cirrhosis 
in rats, where reactive oxygen radicals (ROS) and nitric oxide (NO) participate in 
development of liver damage. Cardiac dysfunction is an important complication of 
liver cirrhosis, but the role of ROS or NO in cardiac abnormalities during liver 
cirrhosis is not well understood. This was investigated in animals after TAA-induced 
liver cirrhosis and temporal changes in oxidative stress, NO and mitochondrial 
function in the heart evaluated. TAA induced elevation in cardiac levels of nitrate 
before development of frank liver cirrhosis, without gross histological alterations. 
This was accompanied by an early induction of P38 MAP kinase, which is influenced 
by ROS and plays an important signaling role for induction of iNOS. Increased 
nitrotyrosine, protein oxidation and lipid peroxidation in the heart and cardiac 
mitochondria, suggestive of oxidative stress, also preceded frank liver cirrhosis. 
However, compromised cardiac mitochondrial function with a decrease in 
respiratory control ratio and increased mitochondrial swelling was seen later, when 
cirrhosis was evident. In conclusion, TAA induces elevations in ROS and NO in the 
heart in parallel to early liver damage. This leads to later development of functional 
deficits in cardiac mitochondria after development of liver cirrhosis.  
Keywords: Heart, Oxidative stress, Liver, p38 MAP kinase, Thioacetamide  
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Introduction 
 
Liver cirrhosis is a chronic disease characterized by hepatic fibrosis induced 
by progressive hepatocyte injury and stellate cell activation. Thioacetamide 
(TAA) administration is a widely used model for development of liver 
cirrhosis in animals which reproduces the human disease induced by a 
number of different etiologies. TAA hepatotoxicity requires its 
biotransformation to TAA-S-oxide and subsequently to the highly reactive 
metabolite TAA-S-dioxide by hepatic microsomal CYP2E1 [1]. Early studies 
from the late 1940s suggest that the liver is the main organ affected by 
administration of TAA [2–4], and chronic feeding of TAA to rats affected 
only the liver with no changes to other organs like the lung, heart, spleen 
[3]. However, only gross abnormalities were generally examined in those 
studies, and the role of reactive oxygen species (ROS) and nitric oxide (NO) 
in cardiac changes after TAA is not well understood. This is relevant since 
cardiac alterations during later stages of cirrhosis in humans could be the 
underlying cause for development of life-threatening complications such 
as the hepatorenal syndrome, ascites, spontaneous bacterial peritonitis 
(SBP) and the hepatopulmonary syndrome [5]. Cirrhotic children have 
cardiac dysfunction mainly in the form of diastolic dysfunction [6], and 
functional deficits in the heart in patients with liver disease may only 
become evident during pharmacological or physiological stress, when 
compensatory mechanisms of the heart become insufficient to maintain 
adequate cardiac output [7]. Though mechanisms involved in cardiac 
dysfunction in hepatic disease are not  fully understood, it has been 
suggested that early detection of this condition is important [8].  
Nitric oxide (NO) is an important vasodilator in the splanchnic and 
systemic circulation at low concentrations, but at higher levels, the 
molecule can have a number of damaging effects. Patients with cirrhosis 
exhibit elevated NO levels in the systemic and splanchnic circulation [9], 
and inhibition of iNOS in cirrhotic rats abrogates the effects of NO and 
improves cardiac contractility, suggesting a role for NO in cardiac 
pathophysiology [10]. In addition, NO can react with free radicals such as 
superoxide resulting in the generation of peroxynitrite, which can enhance 
cellular toxicity [11].  
Oxygen free radicals have been implicated in the pathogenesis of toxic 
liver injury [12], and oxidative stress during liver cirrhosis is responsible for 
intestinal and renal damage [13–15]. Oxidative stress has been suggested 
to be involved in cardiac dysfunction in the cirrhotic heart [16], and an 
increase in lipid peroxidation markers has been demonstrated in the 
kidney, brain and heart of rats with cholestatic liver disease suggesting 
oxidative damage to different organs [17]. Mitochondria are an important 
cellular source as well as target of oxygen free radicals, and intestinal and 
renal mitochondria have been shown to be significantly affected in liver 
cirrhosis [13, 15]. However, the temporal relationship between TAA-
induced development of liver cirrhosis and changes in ROS and NO in the 
heart as well as its effect on cardiac mitochondrial function are not well 
understood and were investigated in this study. We hypothesized that 
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generation of oxygen free radicals and NO during TAA-induced cirrhosis 
results in oxidative and nitrosative damage in the heart, which affects 
mitochondrial function. This hypothesis was tested by examining 
alterations in the rat heart and liver over time after administration of TAA.  
 
 
Methods 
 
Animals and Induction of Liver Cirrhosis  
 
The study was approved by the Institutional Animal Ethics Committee 
(IAEC) at the Christian Medical College, Vellore, and experimentation, 
transportation and care of the animals were performed in compliance with 
relevant laws and institutional guidelines. Adult Wistar rats of both sexes 
(125–200 g) were administered intraperitoneal injections of TAA (200 
mg/kg, ip) in saline twice a week for 2, 3, 4, 5 and 6 months. Some 
experiments had a group treated for 1 month. Control rats received vehicle 
alone [18]. After each treatment period, TAA was stopped and the animals 
were killed after 1 week.  
 
Light and Electron Microscopy (EM)  
 
For light microscopy, tissues were fixed in 10 % buffered formalin and 
processed. Four-micron sections were cut and stained with hematoxylin 
and eosin. For EM, heart tissue was fixed in 2.5 % glutaraldehyde, post-
fixed in osmium tetroxide and embedded in araldite (epoxy resin). One-
micron-thick sections were cut and stained with toluidine blue. Ultrathin 
sections were cut on an LKB UM4 ultramicrotome, sections mounted on 
copper grids, and stained with uranyl acetate and lead citrate. The grids 
were examined under a Philips TECHNAI T12 SPIRIT transmission electron 
microscope.  
 
Measurement of Nitrate and Oxidative Stress Parameters  
 
Nitrate in the samples was measured by the Griess reaction as described 
[19]. Malondialdehyde (MDA), conjugated dienes and protein carbonyl 
content was measured as described [20–22]. Protein was estimated by 
Lowry’s method [23].  
 
Western Blot for p38 MAPK  
 
Twenty-microgram samples of heart protein were separated by SDS-PAGE, 
blotted onto PVDF membrane and probed with anti-p38 MAPK (rabbit 
polyclonal, Cell Signaling Technology) and anti-phospho-p38 MAPK 
(mouse monoclonal, Cell Signaling Technology). Following treatment with 
HRP-linked secondary antibodies, membranes were developed by 
enhanced chemiluminescence and bands quantitated with Image J 
software.  
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Staining for Nitrotyrosine  
 
Paraffin sections were blocked with universal blocking buffer (Biogenex) 
after antigen retrieval, followed by incubation with an anti-nitrotyrosine 
antibody (Clone-39B6) (1:100 dilution, Santa Cruz) overnight at 4 °C. Slides 
were then incubated with secondary antibody, and immunostained 
sections visualized using a confocal microscope (Olympus FluoView™ 
FV1000).  
 
Isolation of Heart Mitochondria and Mitochondrial Functional 
Assays  
 
Heart mitochondria were isolated by differential centrifugation as 
described [13] after homogenization in buffer containing 225 mM 
Mannitol, 75 mM Sucrose, 10 mM Tris, 1 mM EDTA pH 7.4. Mitochondrial 
oxygen uptake and swelling were then measured [13, 24]. MTT assay was 
carried out as described [25].    
 
Statistical Analysis  
 
Data are expressed as mean ± SEM. Statistical analysis was performed 
using Student’s t test. A probability value of <0.05 was taken to indicate 
statistical significance.  
 
 
Results 
 
To confirm development of liver cirrhosis in rats after TAA treatment, liver 
sections from rats treated with either saline or TAA for 3 or 6 months were 
evaluated by light microscopy. Control livers showed normal liver 
architecture (Fig. 1a), with no significant changes in hepatocytes and portal 
tracts. These features were not altered after 2 months of TAA treatment 
(data not shown). However, by 3 months, rats treated with TAA showed 
characteristics of cirrhosis, with the formation of nodules separated by 
septae, infiltration by moderate numbers of inflammatory cells and 
fibroblasts with proliferating bile ductules (Fig. 1b). By 6 months of TAA 
treatment, histological changes in the liver were similar to those seen at 3 
months, but with more uniformly thick septae (Fig. 1c).  
Histological changes in the heart were then examined, and the heart 
from control rats showed normal cardiac muscle fibers with elongated 
nuclei exhibiting fine chromatin and eosinophilic cytoplasm. There was  
no evidence of vacuolization, fibrosis or inflammation (Fig. 1d). The heart 
from cirrhotic rats at both 3 and 6 months of TAA treatment did not show 
any gross cellular abnormality compared to hearts from control rats, 
though congestion of capillaries between cardiac muscle fibers was visible 
(Fig. 1e, f).  
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Nitric oxide has been shown to be involved in cardiac damage after liver 
cirrhosis [11], and further experiments examined the temporal profile of 
nitrate, an NO metabolite, in the heart during TAA-induced cirrhosis. As 
seen in Fig. 2a, nitrate levels increased significantly by 2 months. These 
levels do not change considerably by 3 months, but begin to progressively 
increase further from 4 months, increasing up to 5 months after TAA.  
Probable signaling events controlling this elevation in NO in the heart 
during liver cirrhosis were then examined. Cardiac levels of iNOS mRNA 
and protein have been shown to be elevated in cirrhotic rats [10], and p38 
MAPK has been suggested to be essential for the expression of iNOS in 
cardiac tissue [26]. Western blot analysis showed an increase in levels of 
p38 protein in the heart within a month of treatment with TAA, which did 
not alter significantly subsequently. Activation of p38, as measured by 
phosphorylation at Thr180/Tyr182, was significantly elevated by 1 month 
and increased further at 3 and 5 months after TAA treatment (Fig. 2b). 
Since p38 MAPK can be induced by reactive oxygen species (ROS) [27], the 
presence of ROS was next evaluated in the cirrhotic heart.  
Markers of lipid peroxidation such as malondialdehyde and conjugated 
diene began rising in heart tissue by 2 months of TAA treatment (before 
establishment of gross cirrhotic changes by histology) and peaked by 3 
months when cirrhotic changes in the liver were evident by histology (Fig. 
3a, b). Oxidative changes to cardiac proteins were also evident, as seen by 
an elevation in protein carbonyl content, which was also initiated at 2 
months, but peaked at 4 months, in contrast to lipid peroxidation data (Fig. 
3c). These elevations in malondialdehyde, conjugated diene and protein 
carbonyl content suggest significant oxidant stress in the heart.   
Concurrent elevations in free radicals such as superoxide and NO can 
result in the formation of peroxynitrite, which modifies proteins to 
generate nitrotyrosine. Since both NO and oxidant stress were elevated in 
the heart at early time points, the presence of nitrotyrosine was evaluated 
in the heart as an index of peroxynitrite formation. As seen in Fig. 4, a 
significant increase in staining for nitrotyrosine was evident in the 
cardiomyocytes of the heart by 1 month, concurrent with elevation in NO 
as well as oxidant stress markers.  
Since mitochondria are an important target as well as source of free 
radicals within the cell, we next evaluated cardiac mitochondrial function 
during development of liver cirrhosis. Cardiac mitochondria showed a 
decreased respiratory control ratio (Fig. 5a) which was evident by 3 months 
of TAA treatment and continued until 6 months. This was accompanied by 
an increase in mitochondrial swelling as seen by the decrease in 
absorbance at 540 nm (Fig. 5b) indicative of activation of the mitochondrial 
permeability transition (MPT). This was initiated by 3 months and 
progressively increased until 6 months of TAA treatment. These changes 
were confirmed by electron microscopy, which demonstrated patchy 
cardiac mitochondrial dilation with loss of cristae in animals after 3 (Fig. 
6b, e) or 6 months (Fig. 6c, f) of TAA treatment, while normal control rat 
hearts showed cardiomyocytes with normal mitochondria and myofibrils 
(Fig. 6a, d). Thus, measurements of cardiac mitochondrial functional 
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parameters and electron microscopy indicate that significant functional 
impairment of cardiac mitochondria occur in rats after development of 
cirrhosis. While the oxidative stress in heart tissue was found to start 
increasing at 2 months and peak at 3–4 months followed by a decrease, 
mitochondrial functional alterations were initiated later and were 
progressive (Fig. 5c).  
The role of oxidative stress in mediating these mitochondrial alterations 
was then investigated by measuring the rate of radical production within 
mitochondria using MTT reduction, which has been shown to be elevated 
in kidney and intestinal mitochondria during cirrhosis [13, 15]. As seen in 
Fig. 7a, an increased rate of MTT reduction was evident in cirrhotic rats 
beginning by 3 months, which stayed elevated subsequently. The 
consequence of this elevated mitochondrial radical production was next 
examined, and an increase in malondialdehyde levels was evident in heart 
mitochondria by 2 months of TAA treatment, which peaked by 3 months, 
similar to changes seen in the heart (Fig. 7b). Conjugated diene levels also 
increased by 2 months of TAA treatment and reached a maximum by 3 
months and stayed elevated till 6 months of TAA treatment (Fig. 7c). 
Protein carbonyl content in mitochondria, however, started to increase 
significantly only by 3 months and then peaked at 4 months after TAA 
treatment (Fig. 7d). Thus, lipid peroxidation in the mitochondria seems to 
precede changes in protein oxidation as well as functional defects in 
cardiac mitochondria, implicating it in the subsequent derangement of 
cardiac mitochondrial function during TAA-induced liver cirrhosis.  
 
 
 
Discussion 
 
Thioacetamide Induces Early Elevations in Cardiac Nitric Oxide 
Levels Prior to Liver Cirrhosis  
 
Nitric oxide (NO) has been implicated in renal and cardiac complications 
during liver cirrhosis [11]. Early studies examining cardiac function in biliary 
cirrhosis in the rat suggested a role for NO in pathophysiology of cirrhotic 
cardiomyopathy [28]. It was subsequently shown that cardiac levels of 
TNF-alpha and iNOS mRNA and protein, as well as serum nitrite/nitrate 
levels, were significantly higher in cirrhotic rats than sham controls [10]. 
However, most of the earlier studies examined cardiac alterations after 
development of liver cirrhosis, and our data now show that elevations of 
NO in the heart occur prior to development of frank cirrhosis in the liver 
after administration of TAA. While this is unlikely to be a direct effect of 
TAA since the compound requires hepatic metabolism to produce toxicity 
[29], the role of circulating TAA metabolites in the process cannot be ruled 
out. However, it has been shown that TAA administration does not directly 
produce alterations in the heart [30], and cardiac modifications occurring 
in ascitic rats with biliary cirrhosis are related to NO [28]. The fact that bile 
duct ligation per se, without cirrhosis, resulted in elevation of cardiac 
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mRNA, and protein for iNOS [16] lends further credence to this possibility 
that early liver damage itself can upregulate NO production in the heart 
irrespective of the trigger.  
 
 
Thioacetamide-Induced Liver Injury Results in Early Activation of the 
p38 MAPK  
 
Cholestasis in the liver results in elevated plasma TNF-α in mice, 
accompanied by increased cardiac mRNA and protein expression of p38 
MAPK and iNOS [16]. Activation of p38 MAPK can contribute to loss of 
cardiac contractility [31] and also regulate NO production [32]. Our data 
now show that activation of molecular mediators such as p38 MAPK in the 
heart occurs early in the disease process, in parallel to development of liver 
injury. The initial elevation could be due to increased protein synthesis, but 
subsequently there is a robust phosphorylation of the protein resulting in 
its sustained activation. Activation of p38 MAPK in cholestatic mice was 
accompanied by changes in glutathione and antioxidant enzymes 
suggestive of oxidant stress [16], and the damaging effects of NO can be 
amplified several fold by its reaction with free radical intermediates such 
as superoxide [33], implicating oxidative stress in cardiac damage during 
TAA-induced cirrhosis.  
 
Oxidative and Nitrosative Stress in the Heart Precedes Development 
of Frank Cirrhosis in the Liver  
 
Liver cirrhosis can induce functional alterations in the intestine [13, 14] and 
kidney [15] due to oxidant stress, which has also been demonstrated in 
mice cardiac cells after bile duct ligation [34]. Our data now show that 
elevations in protein carbonyl and malondialdehyde are evident in the 
heart before development of frank cirrhosis in the liver after TAA 
administration. This indicates that oxidant stress in the heart is not merely 
a consequence of liver cirrhosis, but is initiated earlier, before frank 
cirrhosis is evident in the liver. Simultaneous elevations in NO and 
superoxide can result in formation of peroxynitrite, which compromises 
protein function by formation of nitrotyrosine [35]. It has been 
demonstrated that nitration of cardiac proteins is associated with 
abnormal cardiac chronotropic responses in rats with biliary cirrhosis [36]. 
Our data now show elevated nitrotyrosine levels in the heart of TAA-
treated animals within a month after treatment indicating that formation 
of peroxynitrite and nitrosative stress in the heart is also an early event in 
conjunction with oxidant stress.  
 
Liver Cirrhosis Induces Significant Functional Alterations in Cardiac 
Mitochondria  
 
Mitochondria are critical organelles for cellular function, especially in 
energy intensive organs such as the heart, and mitochondrial oxidative 
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stress plays a role in dysfunction of the organelle in heart failure [37]. 
Impaired mitochondrial function and dynamics have been shown to induce 
myocardial contractile dysfunction in patients with type 2 diabetes [38], 
and our data now show that this organelle is a sensitive target in the heart, 
albeit at later stages after development of liver cirrhosis. The uncoupling 
of mitochondrial respiration and oxidative phosphorylation, producing the 
decrease in respiratory control ratio, was evident by 3 months, at which 
time cirrhosis is evident histologically in the liver. A similar decrease in 
respiratory control ratio has been observed in failed human myocardial 
tissue [39], and diabetic hearts were also shown to have lower ATP levels 
and compromised mitochondrial respiration [40]. An important feature of 
cellular injury is activation of the mitochondrial permeability transition 
(MPT) pore, which can be induced by oxidative stress [41]. It is interesting 
that while uncoupling of respiration was evident by 3 months and 
subsequently did not change, the induction of the mitochondrial 
permeability transition was significant only at 4 months and then 
continued to worsen each month until the sixth month. This indicates that 
the MPT induction in cardiac mitochondria was a later event subsequent 
to mitochondrial uncoupling.  
 
Lipid Peroxidation Could Initiate Cardiac Mitochondrial Dysfunction 
in TAA-Induced Cirrhosis  
 
The mitochondrion is a source as well as a target for reactive oxygen 
species, and production of ROS within mitochondria has been 
demonstrated in heart failure [42]. The early elevation in lipid peroxidation 
within cardiac mitochondria by 2 months of TAA, prior to development of 
frank liver cirrhosis, may result in downstream effects since lipid 
peroxidation has been shown to induce uncoupling of mitochondrial 
respiration [43], probably by activation of uncoupling proteins in 
mitochondria [44]. Lipid peroxidation has also been shown in mouse heart 
mitochondria after myocardial infarction when mitochondrial dysfunction 
was evident [45]. Cardiac mitochondrial uncoupling then results in 
elevated free radical production, as seen by MTT reduction which was 
significantly elevated by 3 months, and sustained subsequently. This seems 
to be similar to that seen in both the intestine and the kidney in cirrhotic 
rats [13, 15]. This then suggests that early induction of lipid peroxidation 
in the heart could be responsible for the subsequent mitochondrial 
dysfunction, which exacerbates as the liver injury intensifies.  
In conclusion, we demonstrate early elevations in NO, activation of p38 
MAP kinase, induction of lipid peroxidation and nitrosative stress in cardiac 
tissue prior to development of frank liver cirrhosis after TAA 
administration. Though the mitochondria are likely sources for these free 
radicals, organelle function in the heart is only compromised at later time 
points after development of liver cirrhosis. Thus, while functional cardiac 
alterations occur after development of liver cirrhosis and the resultant 
circulatory abnormalities, molecular alterations within the heart could be 
occurring earlier. While the cardiac changes are probably not responsible 
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for the changes in the liver, the data imply that early changes in the liver 
before development of frank cirrhosis probably induce oxidative and 
nitrosative stress in the heart, which primes the organ for functional 
deficits at later time points after frank cirrhosis has developed. Hence, 
signaling events and subcellular alterations are initiated very early in 
cardiac tissue during development of liver cirrhosis after TAA 
administration, and the cumulative effect of these alterations could play 
an important role in cardiac complications later in liver disease.    
 
 
 
 
 
 
 
 
Fig. 1. Histology of liver and heart from rats treated with TAA: light microscopy of liver (a–c) 
and heart (d–f) from control and rats treated with TAA for either 3 or 6 months. a, d Control; 
b, e 3 months; c, f 6 months. Original magnification ×400.   
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Fig. 2. Nitric oxide and p38 MAPK in the heart during development of liver cirrhosis: a) nitrate 
levels in heart from controls and TAA-treated rats. The data are expressed as mean ± SEM, n 
= 4–6. * P < 0.05 when compared to controls. # P < 0.05 when compared to 5 months. b) 
Phospho-p38 MAP kinase protein expression in heart from controls and TAA-treated rats. 
The data are expressed as mean ± SEM, n = 4. * P < 0.05 when compared to controls.   
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Fig. 3. Oxidative stress parameters in heart from controls and TAA-treated rats: 
malondialdehyde (a), conjugated diene (b) and protein carbonyls (c). The data are expressed 
as mean ± SEM, n = 3–5. * P < 0.05 when compared to controls. 
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Fig. 4. Nitrotyrosine staining in the heart after administration of TAA: immunofluorescence 
staining for nitrotyrosine in sections of cardiac tissue from controls and rats treated with TAA 
for 1 month. NT nitrotyrosine staining, DIC differential interference contrast image, DAPI 
nuclear staining).   
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Fig. 5. Cardiac mitochondrial function after administration of TAA: cardiac mitochondrial 
functional parameters such as respiratory control ratio (a) and mitochondrial swelling (b) 
from controls and TAA-treated rats. The data are expressed as mean ± SEM, n = 3–5. * P < 
0.05 when compared to controls. (c) Overlay of temporal changes in oxidant stress in the 
heart and cardiac mitochondrial function in animals treated with TAA when compared to 
controls.   
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Fig. 6. Electron micrographs of hearts from rats treated with TAA: control animals showing 
normal mitochondria (a ×6000, b ×43,000) (arrows). Cardiac tissue after 3 (c ×6000, d 
×43,000) and 6 (e ×6000, f ×43,000) months showing mitochondrial dilation with loss of 
cristae (asterisks).   
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Fig. 7. Superoxide production and oxidative stress parameters in cardiac mitochondria from 
cirrhotic rats: MTT reduction (a) and oxidative stress parameters such as malondialdehyde 
(b), conjugated diene (c) and protein carbonyls (d) in cardiac mitochondria from controls 
and TAA-treated rats. The data are expressed as mean ± SEM, n = 3–5. * P < 0.05 when 
compared to controls.    
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